Guardant Health’s Shield blood test has already been used by hundreds of thousands of people since its 2025 launch, with the company targeting millions of tests as it works to reach the estimated 54 million Americans who are unscreened or overdue for colorectal cancer screening.…
Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting…
Olympus’ $1M+ equipment grant to ASGE isn’t just philanthropy—it’s a strategic investment in shaping the next generation of endoscopists and,…
Walgreens is taking colorectal cancer screening out of the clinic and into retail—partnering with Exact Sciences to offer Cologuard access…
Evaluating the analytical performance of direct-to-consumer gut microbiome testing services (Nature)
This study evaluates the analytical reliability of direct-to-consumer (DTC) gut microbiome testing services. As consumer interest in gut health rises,…
DDW 2026
Several studies presented at DDW 2026 highlighted emerging approaches that could reshape…
A structured triage system for interventional GI referrals changed the originally requested…
Headlines in GI
A routine endoscope demonstration at a Texas hospital allegedly turned into a…
PENTAX Medical is expanding its partnership with MAGENTIQ EYE beyond the U.S.,…
Thought Leadership
In a wide-ranging interview, Byron L. Cryer, MD, president of the American Gastroenterological Association and chairman of internal medicine at Baylor University Medical Center,…
The hidden cost of administrative work extends far beyond unpaid overtime, according…
The microbiome field is undergoing a fundamental shift—from cataloging which microbes are…
As direct-to-consumer microbiome testing becomes more popular, clinicians are calling for stronger…
ARTIFICIAL INTELLIGENCE (AI)
An AI-powered Red Density (RD) Score that measures colonic mucosal redness at the pixel level predicted long-term clinical outcomes in…
Tech & Innovation
Houston Methodist researchers developed an explainable machine-learning model that distinguishes Crohn’s disease, ulcerative colitis and patients without IBD using electronic medical record data, addressing the limitations…
Editor's Picks
Guardant Health’s Shield blood test has already been used by hundreds of…
Business
PENTAX Medical is expanding its partnership with MAGENTIQ EYE beyond the U.S.,…
Exponential Tech
Houston Methodist researchers developed an explainable machine-learning model that distinguishes Crohn’s disease,…
Leadership
Medscape’s 2026 gastroenterologist well-being survey reveals a profession struggling to practice what…
Patient Trends
A new population-based study published in Clinical Gastroenterology and Hepatology evaluated the…
